Ligand Pharmaceuticals, Inc. (LGND)
284.47
-4.78
(-1.65%)
USD |
NASDAQ |
Sep 11, 16:00
284.47
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 284.47 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 291.48 | 294.00 | 283.77 | 284.47 | 261167.0 |
| Sep 10, 2026 | 285.00 | 291.26 | 283.04 | 289.25 | 146553.0 |
| Sep 09, 2026 | 288.03 | 291.82 | 285.48 | 288.05 | 309964.0 |
| Sep 08, 2026 | 285.05 | 289.28 | 278.40 | 288.83 | 216423.0 |
| Sep 04, 2026 | 287.41 | 290.00 | 285.47 | 285.60 | 132389.0 |
| Sep 03, 2026 | 286.92 | 290.08 | 281.88 | 289.74 | 190729.0 |
| Sep 02, 2026 | 285.73 | 290.33 | 281.69 | 286.92 | 189615.0 |
| Sep 01, 2026 | 286.28 | 290.41 | 281.99 | 284.27 | 185017.0 |
| Aug 31, 2026 | 276.77 | 285.90 | 275.60 | 284.10 | 203702.0 |
| Aug 28, 2026 | 283.70 | 284.00 | 277.36 | 280.49 | 127696.0 |
| Aug 27, 2026 | 284.71 | 289.20 | 282.40 | 284.52 | 206326.0 |
| Aug 26, 2026 | 281.72 | 289.66 | 277.01 | 287.85 | 147463.0 |
| Aug 25, 2026 | 284.22 | 287.90 | 278.28 | 281.72 | 197406.0 |
| Aug 24, 2026 | 286.27 | 286.27 | 279.87 | 280.18 | 158235.0 |
| Aug 21, 2026 | 288.09 | 289.98 | 285.21 | 286.29 | 152536.0 |
| Aug 20, 2026 | 289.11 | 293.37 | 284.87 | 287.39 | 138945.0 |
| Aug 19, 2026 | 291.02 | 294.60 | 282.25 | 290.71 | 231199.0 |
| Aug 18, 2026 | 291.00 | 293.51 | 284.41 | 287.59 | 247481.0 |
| Aug 17, 2026 | 292.47 | 298.29 | 291.73 | 291.77 | 145604.0 |
| Aug 14, 2026 | 287.61 | 295.19 | 287.20 | 294.60 | 197210.0 |
| Aug 13, 2026 | 294.99 | 294.99 | 285.24 | 288.82 | 255440.0 |
| Aug 12, 2026 | 290.38 | 294.74 | 287.81 | 293.27 | 380028.0 |
| Aug 11, 2026 | 295.01 | 299.34 | 288.60 | 288.75 | 368556.0 |
| Aug 10, 2026 | 295.51 | 299.38 | 288.46 | 295.70 | 192188.0 |
| Aug 07, 2026 | 304.37 | 304.60 | 286.65 | 293.15 | 313612.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 265.58 |
| Eli Lilly & Co. | 1115.70 |
| Merck & Co., Inc. | 143.93 |
| Zevra Therapeutics, Inc. | 12.01 |
| Liquidia Corp. | 66.74 |
Price Related Metrics
| PE Ratio | 30.41 |
| PS Ratio | 20.44 |
| Price to Book Value | 5.857 |
| Price to Free Cash Flow | 49.55 |
| Earnings Yield | 3.29% |
| Market Cap | 5.667B |
| Operating PE Ratio | 59.32 |
| Normalized PE Ratio | 40.42 |